This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2021 Sep 21;326(11):1069-1070.

doi: 10.1001/jama.2021.11480.

Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply

Silje Watterdal Syversen¹, Nils Bolstad², Espen A Haavardsholm¹

Affiliations

Affiliations

¹ Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
² Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

PMID: 34546304
DOI: 10.1001/jama.2021.11480

Comment

Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases-Reply

Silje Watterdal Syversen et al. JAMA. 2021.

. 2021 Sep 21;326(11):1069-1070.

doi: 10.1001/jama.2021.11480.

Authors

Silje Watterdal Syversen¹, Nils Bolstad², Espen A Haavardsholm¹

Affiliations

¹ Division of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
² Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.

PMID: 34546304
DOI: 10.1001/jama.2021.11480

No abstract available

PubMed Disclaimer

Comment on

Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
Papamichael K, Dubinsky MC, Cheifetz AS. Papamichael K, et al. JAMA. 2021 Sep 21;326(11):1067. doi: 10.1001/jama.2021.11477. JAMA. 2021. PMID: 34546306 No abstract available.
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
Le Tilly O, Paintaud G, Ternant D. Le Tilly O, et al. JAMA. 2021 Sep 21;326(11):1069. doi: 10.1001/jama.2021.11474. JAMA. 2021. PMID: 34546307 No abstract available.
Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.
Serkland TT, Skrede S, Berg JA. Serkland TT, et al. JAMA. 2021 Sep 21;326(11):1068-1069. doi: 10.1001/jama.2021.11471. JAMA. 2021. PMID: 34546308 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems